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PKC putative phosphorylation site Ser
235 is required for MIP/AQP0
translocation to the plasma membrane
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Purpose: To investigate the functional significance of MIP/AQP0 phosphorylation at serine235.
Methods: MIP/AQP0 expression and cellular localization was studied in rat lens epithelia explants induced to differentiate
by FGF-2. MIP wild type (WT) and MIP (S235A) mutant expression plasmids were constructed and transiently expressed
in RK13 cells. Subcellular localization of endogenous MIP in differentiating lens epithelia explants or of transfected MIP
expression vectors in RK13 cells was analyzed by immunofluorescence confocal microscopy.
Results: MIP/AQP0 expressed in lens epithelia explants induced to differentiate by FGF-2 localizes to the plasma
membrane of elongating cells. However, MIP/AQP0 translocation to the plasma membrane was prevented by inhibiting
PKC activity with Go6976, resulting in retention in the cytoplasmic compartment. This effect was specific to MIP/AQP0;
localization of AQP1 to the cell membrane was not affected by Go6976. When the consensus PKC phosphorylation site
at MIP Ser235 was mutated to alanine and transiently expressed in transfected RK13 cells, the mutant MIP was retained
in the cytoplasmic compartment in contrast to WT MIP that localized to the plasma membrane of the transfected RK13
cells. Colocalization studies indicated that the mutant MIP was retained in the trans-Golgi network.
Conclusions: Our results indicate that serine235 is required for proper intracellular transport of MIP/AQP0 from the trans-
Golgi network to the plasma membrane. A PKC dependent phosphorylation event involving MIP at serine235 is most likely
involved in this process.
MIP/AQP0 is the major intrinsic protein of the ocular
lens. It is specifically expressed in the lens fibers. Mutations
in the MIP/AQP0 gene result in genetic cataracts in mice and
humans [1-11]. In the last decade, great advances have been
made in understanding the function of this protein, which is
also known as “the founder of the MIP or aquaporin gene
family.”  Initially  it  was  considered  to  be  a  gap  junction
protein. Even though it was later found not to be a member of
the  connexin  gene  family,  it  was  demonstrated  that  MIP
interacts transiently with some connexins and appears to be
involved in gap junction formation [12-14]. It functions as a
water channel when tested in various functional assays [2,
15-23]. However, MIP/AQP0 has also been demonstrated to
have  additional  functions  such  as  acting  as  an  adhesion
molecule [24,25], forming thin junctions [26-29], and playing
a role in the correct formation of sutures in the ocular lens
[30-33]. In this way, MIP/AQP0 contributes to the minimal
intercellular  space  between  the  lens  fibers  and  suture
formation required for optimal focusing and transparency of
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the  lens  [7,8,22,30].  The  MIP  COOH-terminal  domain
interacts with other lens proteins such as gamma crystallins
[34,35],  filensin,  CP49  [36],  and  connexins  [13].
Posttranslational modifications of MIP such as proteolysis
[26,37,38] and phosphorylation [15,36-41] may play a role in
regulating the various functions that MIP is able to play in the
lens for maintaining lens transparency.
However, regulation of the function of MIP/AQP0 by
signaling  pathways  during  lens  differentiation  is  not
understood as well. We have previously demonstrated that the
ERK  and  JNK  signaling  pathways  are  involved  in  the
regulation of expression of the MIP gene during the induction
of lens epithelia differentiation by FGF-2 [42]. In this study,
we demonstrate that although the PKC signaling pathway
does not regulate MIP transcription, it does play an essential
role in the trafficking of MIP/AQP0 from the Golgi apparatus
to the plasma membrane to be able to perform its physiologic
function in the ocular lens.
METHODS
Chemicals and reagents: Turbo Pfu DNA polymerase was
obtained from Stratagene (La Jolla, CA). The Polymerase
Chain Reaction (PCR) Purification Kit and The Plasmid Midi
and Maxi Kits were purchased from Qiagen (Valencia, CA).
PKC inhibitor, Go6976, was obtained from Calbiochem (San
Diego,  CA).  Dimethylsulfoxide  (DMSO)  and  4’,6-
diamidino-2-phenylindole  dihydrochloride  (DAPI)  were
obtained from Sigma-Aldrich (St. Louis, MO). Alexa 555-
streptavidin and Alexa 488-streptavidin were from Molecular
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1006Probes (Eugene, OR). All other chemicals were reagent grade
and from standard commercial sources.
Antibodies:  The  MIP-specific  rabbit  polyclonal  antiserum
was  obtained  from  Alpha  Diagnostic  (San  Antonio,  TX).
Antibodies to Aquaporin 1 (mouse monoclonal), trans-Golgi
network marker 38K (mouse monoclonal TGN38), goat anti-
rabbit  biotinylated,  and  anti-mouse  biotinylated  were
purchased from Abcam (Cambridge, MA).
Plasmids: All plasmid DNAs used were propagated in E. coli
strain, DH5α or DH10B, and were purified by ion exchange
chromatography using Plasmid Midi Kits or Endonuclease-
Free Maxi Kits from Qiagen (Valencia, CA).
Plasmid  constructions:  The  plasmid,  pCMVScript,  was
purchased from Stratagene. The expression vector for wild
type mouse MIP (pCMV-MIP) was constructed as indicated
before [35]. The expression vector for Ala235 mutant MIP
(pCMV-  MIP  Ala235)  was  constructed  by  site-directed
mutagenesis of MIP in pCMV-MIP, which was accomplished
by use of Quick Change II Site-Directed Mutagenesis Kit
(Stratagene) according to the manufacturer’s instructions. The
introduced mutation Ala235 was verified by DNA sequencing.
DNA sequencing: DNA sequencing of plasmid constructions
was  performed  using  a  commercial  system  (CEQ  DTCS-
Quick  Start  Kit;  Beckman-Coulter,  Hialeah,  FL)  and  an
automated DNA analysis system (CEQ 2000XL; Beckman-
Coulter) according to the manufacturer’s instructions.
Lens  epithelia  explant  culture:  Eyes  were  dissected  from
three-day-old  Sprague  Dawley  rats  (Charles  River
Laboratories,  Wilmington,  MA).  The  lens  capsule  with
adhering epithelial cells was micro-dissected from the lens
fibers and pinned down around its periphery with forceps onto
the surface of either a 35 mm or 60 mm culture dish in Medium
199. The resulting lens epithelia explants were pre-incubated
for  1  h  in  Medium  199  containing  either  0.2%  DMSO
(control) or PKC inhibitor (4 μM Go6976%–0.2% DMSO)
before adding the culture medium. The lens epithelia explants
(three  to  five  explants  per  culture  dish)  were  cultured
according to the method previously described [42] in Medium
199 containing 0.1% BSA, 1% gentamicin, and 100 ng/ml
FGF-2  (Sigma  Chemical  Co,  St.  Louis,  MO)  to  induce
differentiation [42,43] The control contained 0.2% DMSO
and experimental with PKC inhibitor 4 μM Go6976 - 0.2%
DMSO. The medium was changed every 24 h. All animals
were  treated  in  compliance  with  the  guidelines  of  the
Association for Assessment and Accreditation of Laboratory
Animal  Care  International  (AAALAC  International).  The
study protocol was approved by the National Institutes of
Health Animal Care and Use Committee.
Cell line: The RK13 (rabbit kidney) cell line was obtained
from  the  American  Type  Culture  Collection  and  was
maintained as monolayer cultures at 37 °C in a 5% CO2/95%
air  incubator  in  Dulbecco's  Modified  Eagle's  Medium
(DMEM)  supplemented  with  10%  heat  inactivated  fetal
bovine serum (FBS).
Transfections of the RK13 cell line: After 24 h in culture, the
cells were transfected with the plasmid constructions, pCMV-
WT MIP and pCMV- Ala235 MIP (5 μg), using the Superfect
Transfection Reagent (Qiagen) as previously described [35].
Cells were incubated with the transfection mixture for 5 h. The
medium was changed every 24 h. Forty eight hours after
transfection (three days in culture), the cell were fixed in 4%
paraformaldehyde for immunocytochemistry.
RNA isolation and reverse transcription polymerase chain
reaction:  Explants  were  removed  with  forceps  under  the
dissecting microscope at the end of the culture period, and
RNA was isolated from 10 explants by using the Absolutely
RNA Nanoprep Kit (Stratagene, Cedar Creek, TX) according
to the manufacturer’s protocol. cDNA was prepared with the
SuperScript  First-Strand  Synthesis  System  for  reverse
transcription  polymerase  chain  reaction  (RT–PCR;
Invitrogen, Carlsbad, CA).
Relative quantification of gene expression using real-time
polymerase chain reaction: Relative amounts of MIP mRNA
and that of the control gene were quantified by real-time PCR
using  the  ABI  Prism  7900  Sequence  Detection  System
(Applied Biosystems, Foster City, CA). Primers and probe
design for the real-time PCR was made with Primer Express
version 2 from Applied Biosystems. The MIP-specific primer
pair were 5′ CAC CAG CTG TCC GAG GAA A 3′ (forward)
and 5′ GCG TCA GGA AGA TCT CCA CAG T 3′ (reverse),
and the probe (FAM-MGB) specific for MIP was FAM −5′
TCA ACA CGC TGC ATG C 3′-MGB. Primers for mouse
18S rRNA (as control) were 5′ AGT CCC TGC CCT TTG
TAC ACA 3′ (forward) and 5′ CCG AGG GCC TCA CTA
AAC C-3′ (reverse), and the VIC-Tamra probe sequence for
18S rRNA was 5′ CCC ATC AAC AGA GAG CGA ACT 3′.
The MIP forward primer spans the exon 1–exon 2 boundary
to avoid amplification of possible contamination of the MIP
genomic  sequence.  All  runs  were  performed  in  triplicate
according to the default PCR protocol (50 °C for 2 min, 95 °C
for 10 min, and 40 cycles of 95 °C for 15 s and 60 °C for 1
min) or the default one-step RT–PCR protocol (42 °C for 30
min, 95 °C for 10 min, and 40 cycles of 95 °C for 15 s and
60 °C for 1 min). Relative standard curves were generated for
each  primer  set  so  that  the  input  amount  from  unknown
samples  could  be  calculated.  Expression  of  MIP  was
normalized with 18S rRNA expression.
Confocal  immunofluorescence:  The  lens  explants  and  the
transfected RK13 cell line were fixed in 4% formaldehyde in
isotonic PBS (pH 7.4) buffer for 2 h at room temperature.
Cellular localization of MIP, aquaporin 1, or TGN 38K either
in the transfected cells or in the explants was examined by
indirect immunofluorescence labeling. Briefly, the explants
or the cells were incubated in ICC buffer (PBS containing
0.20% Tween 20, 0.05% sodium azide, and 0.5% BSA, pH
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were then incubated in ICC buffer with rabbit polyclonal anti-
MIP (1:50) and mouse monoclonal anti-aquaporin 1 (1:50) for
1 h at 37 °C. The RK13 cells were incubated with rabbit
polyclonal anti-MIP (1:50) and mouse monoclonal anti-TGN
38K (1:50) for 1 h at 37 °C. The explants or the cells were
washed in ICC buffer followed by incubation for 1 h in ICC
buffer  containing  fluorescent  dye-conjugated  secondary
antibodies  (goat  anti-rabbit  biotinylated  and  Alexa  555-
streptavidin  or  anti-mouse  biotinylated  and  Alexa  488-
streptavidin) along with either DAPI or SYTOX green dye.
Extensive washing was performed after each incubation step.
After washing, the samples were mounted with TBS/glycerol
(1:1)  containing  p-phenylenediamine  (Sigma-Aldrich,  St.
Louis, MO) and covered by a coverslip. Samples were stored
at  4  °C  until  they  were  imaged  by  confocal  fluorescence
microscopy.
The stained and mounted cells in 60 mm culture dishes
were imaged using a Leica TCS SP2 confocal microscope
(Leica Microsystems, Exton, PA) with a Leica 40X HCX Plan
Apo CS 0.85 NA and a Leica 40X Oil HCX Plan Apo CS
0.75–1.25 NA objective lens.
RESULTS
PKC inhibitor does not affect MIP transcription in rat lens
explants: We have previously shown that induction of rat lens
epithelia explant differentiation into lens fibers by FGF-2
involves the activation of transcription of the MIP/AQP0 gene
through  the  activation  of  the  FGF  downstream  signaling
components, ERK and JNK [42].
To examine whether PKC signaling was also involved in
activating  MIP  transcription  during  lens  epithelia
differentiation induced by FGF-2, we investigated whether the
synthetic inhibitor to PKC, Go 6976 [44], would affect MIP
mRNA levels. We quantitated the MIP mRNA amounts in the
untreated control and PKC inhibitor-treated explants using
real-time PCR analyses. As shown in Figure 1, no significant
change in MIP transcript levels was observed in the control
and PKC inhibitor-treated explants. These results imply that
unlike  ERK  and  JNK,  PKC  signaling  (at  least  through
isoenzymes α, γ, and μ [44,45]) does not contribute to MIP
transcription.
PKC inhibitor affects MIP plasma membrane localization in
rat lens explants: Our results show that PKC is not involved
in regulating MIP at the level of transcription. As PKC has
been reported to have a possible role in MIP phosphorylation
[46], we set up to investigate the role of PKC as a potential
contributor to the subcellular localization of MIP. Thus, we
studied  the  effect  of  the  PKC  inhibitor,  Go6976,  in  the
localization of expressed MIP in rat lens epithelia explant
cultures induced to differentiate by FGF-2. As we previously
demonstrated [42], MIP expressed in rat epithelia explants and
induced to differentiate by FGF-2 localizes to the plasma
membrane of elongating cells that characterize the first stages
of lens epithelia differentiation as shown in Figure 2A,C and
animation 1. However, when the PKC inhibitor, Go6976, is
present  during  FGF-2-induced  lens  epithelia  explants
differentiation, MIP immunofluorescence shows that cells in
explants treated with the PKC inhibitor retained MIP in the
cytosolic compartment (Figure 2B,D and animation 2). These
results implied the importance of PKC isoenzymes (α, γ, and/
or μ [44,45]) in MIP targeting to the plasma membrane in
differentiating lens cells.
Inhibition of PKC perturbs MIP/AQP0 translocation to the
plasma membrane but does not affect AQP1 localization to
the plasma membrane of rat lens explants: To distinguish
whether the inhibition of PKC isoenzymes by Go6976 [44,
45] specifically affects the localization of MIP to the plasma
membrane or if it is the result of a general effect on membrane
proteins  due  to  other  pathways  being  affected  in  the
differentiating  lens  epithelia  cells,  we  also  looked  at  the
possible  effect  of  the  PKC  inhibitor  Go6976  on  the
localization of AQP1. AQP1 is expressed in the anterior and
equatorial  lens  epithelia.  As  the  lens  epithelial  cells  start
differentiating into lens fibers, AQP1 expression is turned off
and MIP/AQP0 expression is turned on [22]. The induction of
lens epithelia differentiation by FGF-2 into lens fibers in the
rat explant system allows us to study the expression of both
proteins during this transition period. As shown in Figure
3A,B, both MIP/AQP0 and AQP1 are expressed and localized
to the plasma membrane in the lens explant cells. When the
explants are incubated in the presence of Go6976, MIP/AQP0
accumulates  in  the  cytoplasmic  compartment  (Figure  3D)
Figure 1. PKC inhibitor does not affect MIP transcription in rat lens
explants. Real-time PCR analysis is shown of Mip mRNA from rat
lens epithelia explants cultured for 72 h with 100 ng/ml FGF-2 in the
absence  (red)  or  presence  of  Go6976  (4  μM;  blue  hatched)  as
indicated in Methods. Standard deviations are indicated in green. The
endogenous Mip mRNA level is not significantly affected in rat lens
explants treated with PKC inhibitor, Go6976.
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1008whereas AQP1 localization into the cell plasma membrane is
not affected (Figure 3E). These results clearly demonstrate
that PKC isoenzymes inhibited by Go6976 (α, γ, and/or μ
[44,45]) affect only MIP/AQP0.
Mutation  of  PKC  putative  phosphorylation  site  (Ser235)
prevents MIP targeting to the cell plasma membrane: It has
been reported that PKC is involved in the phosphorylation of
MIP  [46].  We  identified  MIP  Ser235  as  a  potential  PKC
phosphorylation site in the MIP protein by analyzing it with
the Scansite program [47]. Serine235 coincides with the major
phosphorylated site identified in MIP in vivo in the lens of
several species [38,39,41]. Based on this identification, the
putative PKC phosphorylation site, Ser235, was mutated to
Ala235 in the MIP cDNA. As we have previously demonstrated
that MIP transiently expressed in RK13 cells localizes to the
plasma membrane [35], we investigated whether the Ala235
mutation of MIP Ser235 would affect the localization to the
plasma membrane when expressed in these cells. Therefore,
RK13 cells were transfected with either the WT or mutant MIP
cDNA  expression  vectors.  Immunofluorescence  of  the
transfected cells was performed to identify the localization
pattern of the expressed MIP. In cells transfected with WT
MIP cDNA, the translated MIP protein was localized to the
cell  plasma  membrane  (Figure  4A,E).  However,  in  cells
expressing  the  MIP-Ala235,  a  cytoplasmic  retention  of  the
protein was evident; the bulk of the mutant protein shows a
punctate expression in the intracellular compartment and no
localization in the plasma membrane (see Figure 4J,N). These
results show that mutation of a single PKC phosphorylation
site in the MIP protein prevents its targeting to the plasma
membrane.
Membrane  proteins  synthesized  in  the  endoplasmic
reticulum undergo proper folding and oligomerization before
being  routed  through  the  Golgi  apparatus  and  the  Golgi
vesicles to their final destination in the plasma membrane.
Therefore, we investigated whether the WT and mutant MIP
expressed in the transfected RK 13 cells were differentially
processed in subcellular compartments such as trans-Golgi
vesicles. We used an antibody to the trans-Golgi network
(TGN) marker 38K along with the MIP antibody to determine
Figure 2. PKC inhibitor prevents MIP
membrane  localization  in
differentiating  lens  explants.  MIP
immunofluorescence (red) shows MIP
localization in the cell membrane (A,C;
indicated with large arrows) of rat lens
epithelial explants cultured in 100 ng/ml
FGF-2  and  0.2%  DMSO  for  72  h
(control; as described in Methods; A and
C).  MIP  is  retained  in  the  cytosolic
compartment (B,D; large arrows point
to cell with strong MIP signal in the
cytoplasmic  compartment;  numerous
MIP-positive vesicles were also seen,
small  arrow)  in  rat  lens  epithelial
explants cultured for 72 h (100 ng/ml
FGF-2 in the presence of 4 μM Go6976
plus  0.2%  DMSO  as  described  in
Methods;  panels  B  and  D).  C  and  D
show  the  merged  images  of  MIP
immunofluorescence  (A  and  B,
respectively)  with  the  ones  for  green
nuclei  staining.  Green  fluorescence
indicates  nuclei  stained  with  SYTOX
green dye. Scale bars represent 20 μm. C
and D show one of the z stack confocal
images  of  MIP  immunofluorescence
cell distribution through the thickness of
the  cultured  explant  in  the  control
(animation 1) and Go6976 (animation 2)
experiments, respectively. Note that the
slide bar at the bottom of the quicktime
movie can be used to manually control
the flow of the movie. If you are unable
to  view  the  movie,  a  representative
frame is included.
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1009whether they colocalized. The 38K TGN marker, an integral
protein  predominantly  localized  to  the  TGN,  is  also  a
component of the TGN-derived vesicles in route to the plasma
membrane and can be observed at the plasma membrane. WT
MIP  colocalizes  with  the  TGN  vesicles  in  the  plasma
membrane as shown in Figure 4I (peaks indicated with blue
lines) and Figure 4D (right peak indicated with blue line); it
also shows colocalization with the trans-Golgi network in the
cytoplasmic compartment in route to the plasma membrane
(Figure 4; yellow pattern in Figure 4C and Figure 4G; left peak
indicated with blue line in Figure 4D). In contrast, in cells
expressing the MIP mutant Ala235, MIP is absent from the
plasma membrane, showing a punctate distribution (Figure
4J,N). There is colocalization with the trans-Golgi network
only  in  the  cytoplasmic  compartment  (Figure  4;  yellow
pattern in Figure 4L and Figure 4P) besides localization in
other cytoplasmic vesicles. There is no colocalization of MIP
mutant  Ala235  with  the  TGN  vesicles  at  the  cell  plasma
membrane (Figure 4M,Q). These results demonstrate that the
PKC putative phosphorylation site Ser235 plays a prominent
role in the process of MIP translocation from the TGN to the
plasma membrane by the TGN vesicles.
DISCUSSION
The PKC pathway is one of the major signal transduction
pathways  that  regulate  a  multitude  of  biologic  functions.
Most,  if  not  all,  membrane  proteins  continuously  shuttle
between  several  organelles  along  microtubules  and  actin
cytoskeleton [48,49]. The dynamic equilibrium of this protein
subcellular  transport  is  regulated  by  several  factors  that
include the activity of protein kinases and phosphatases; PKC
is one of the protein kinases implicated in this trafficking
[50-53]. Several members of the PKC family are expressed in
the lens [54-56]. The role of the PKC γ isozyme on the lens
gap junction function has been well documented [54-63], and
PKC α isozyme may regulate the interaction of tropomodulin
with cytoskeletal components in the lens [64].
PKC  may  be  a  possible  contributor  to  MIP
phosphorylation  [46],  and  phosphorylated  MIP  is
differentially distributed in the lens cortex and nucleus of the
human lens [37]. In this study, we examined the role of active
PKC  on  MIP  expression  and  subcellular  localization  in
differentiating lens cells. Our real-time PCR results which
showed that the level of MIP transcripts in rat lens explants
were unaffected by a PKC inhibitor to isozymes α, γ, and μ
indicated that these PKC isozymes are not required for MIP
gene  expression.  However,  we  found  that  active  PKC
isozymes  (α,  γ,  and/or  μ)  play  an  important  role  in  MIP
translocation  to  the  plasma  membrane.  PKC  inhibition
prevents MIP integration in the plasma membrane, resulting
in retention in the cytoplasmic compartment of lens epithelia
Figure 3. PKC inhibitor perturbs MIP/AQP0 membrane localization without affecting AQP1 membrane localization in differentiating lens
explants. Images are shown of MIP/AQP0 immunofluorescence (red; A) and AQP1 immunofluorescence (green; B) in rat lens epithelial
explants cultured in 100 ng/ml FGF-2 and 0.2% DMSO for 72 h (control, as described in Methods). Images are shown of MIP/AQP0
immunofluorescence (red; D) and AQP1 immunofluorescence (green; E) in rat lens epithelial explants cultured in 100 ng/ml FGF-2 in the
presence of 4 μM Go6976 plus 0.2% DMSO for 72 h (as described in Methods). C and F show the merged images of MIP/AQP0
immunofluorescence and AQP1 immunofluorescence and the DAPI nuclear staining in controls (A and B) and Go6976 experiments (D and
E), respectively. Scale bars represent 20 μm.
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1010Figure 4. Mutation of PKC putative phosphorylation site (Ser235) prevents MIP translocation from the trans-Golgi network to the plasma
membrane. Immunofluorescence of RK13 cells transfected with pCMV- MIP (WT; A-I) or pCMV-MIP Ala235 (S235A; J-Q) for 72 h is shown.
A and E as well as J and N show the merged images of MIP red immunofluorescence with the corresponding images of their DAPI nuclear
staining. B and F as well as K and O show the trans-Golgi network marker 38K (TGN) green immunofluorescence. C, G, L, and P show the
merged images of MIP immunofluorescence and DAPI nuclear staining with their respective TGN green immunofluorescence (A and B; E and
F; J and K; N and O, respectively). Spatial quantification was performed along a path across the plasma membrane, indicated by a white line
with prominent end points in the merged images (C, G, L, and P). Red and green fluorescence was quantified separately and plotted as a
function of distance along the path (D, I, M, and Q). Blue broken lines in the spatial quantification graphs indicate the approximate location
of the plasma membrane (except the left line in D, which corresponds to the TGN region in C). Note that WT MIP and TGN vesicles colocalize
at the plasma membrane (peaks are indicated with blue lines in I and right peak in D). MIP Ala235 mutant (S235A) does not colocalize with
TGN vesicles at the plasma membrane (blue lines; M and Q). C and G show colocalization (yellow) of WT MIP (red immunofluorescence)
and TGN 38K (green immunofluorescence) in the cytoplasmic compartment in addition to the localization of WT MIP in the plasma membrane.
J and N show MIP Ala235 mutant punctate distribution in the cytosolic compartment (red immunofluorescence) and colocalization (yellow)
with trans-Golgi network 38K (green) in L and P. A and E as well as J and N show cell images from either duplicate experiments or in different
fields of the same cell culture of WT or MIP Ala235 mutant (S235A), respectively. Scale bars represent 10 μm. Note that three cells in A, B, and
C (one cell at the right side and two cells in the upper part of the panels) that did not uptake the transfected MIP expression plasmid served
as negative controls. They show no red immunofluorescence in contrast to two transfected cells showing the red immunofluorescence. All the
cells in the panel (transfected and non-transfected) show green immunofluorescence for TGN38.
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1011explants that were induced to differentiate by FGF-2. This
effect  was  specific  for  MIP/AQP0;  AQP1  membrane
localization  in  the  lens  explants  was  not  affected  by  the
inhibitor to PKC isoenzymes α, γ, and μ.
We  then  focused  on  MIP  serine235,  a  putative  PKC
phosphorylation site that has also been identified as a major
MIP phosphorylation site in rat, bovine, and human lens [38,
39,41]. Our results showed that mutation of MIP serine235 to
alanine235 prevents translocation of MIP-Ala235 mutant from
the  trans-Golgi  network  to  the  plasma  membrane  of
transfected RK13 cells. The additional punctate distribution
of the mutant MIP in the cytoplasmic compartment probably
represents its targeting from the trans-Golgi to the degradation
pathways (i.e., lysosomal vesicles).
Natural  mutations  in  MIP,  either  deletions  or
substitutions, have been linked to genetic cataracts with a
dominant phenotype in mice and humans [1-11]. Some of
those MIP mutants with mutations involving transmembrane
domains are retained in the endoplasmic reticulum [5,6,8,9].
As MIP assembles as a tetramer [26,28], these MIP mutations
prevent oligomerization and correct folding required for MIP
transport  from  the  endoplasmic  reticulum  to  the  Golgi
apparatus.  Our  present  results,  which  indicate  that
phosphorylation of MIP at serine235 is required for proper MIP
translocation  from  the  trans-Golgi  network  to  the  plasma
membrane, reveal a novel control point in the MIP trafficking
possibly serving as a sorting signal. PKC-dependent serine
phosphorylation  has  also  been  identified  as  Golgi  sorting
signals  of  other  proteins  such  as  NMDA  receptors  and
phosphatidylinositol transfer protein β [65-68]. As PKC μ/
PKD  localizes  to  the  trans-Golgi  network  and  regulates
vesicle  formation  required  for  trafficking  of  membrane
proteins to the plasma membrane [69,70], it is tempting to
speculate that PKC μ may play a role in MIP trafficking to the
plasma membrane from the trans-Golgi network.
MIP/AQP0 serine235 is located in the COOH-terminal
domain, which is involved in interactions with other proteins
in the lens such as gamma crystallins [34,35], filensin, CP49
[36], connexins [13], and calmodulin [71]. Phosphorylation
of  MIP  COOH-terminal  domain  reduces  its  affinity  for
calmodulin [71], known to regulate water channel activity in
functional assays [20,21,71]. Thus, phosphorylation of MIP/
AQP0 at Ser235 may be involved in regulating its functions
once  integrated  in  the  plasma  membrane.  We  have  now
demonstrated in this study that MIP phosphorylation at Ser235
is required for correct trafficking to the plasma membrane;
therefore, this phosphorylation event plays a primary role in
MIP function by being required for proper targeting to the
plasma membrane. Once MIP/AQP0 is correctly integrated in
the plasma membrane, it becomes enabled to accomplish its
functions  in  the  lens,  such  as  water  channel,  adhesion
molecule  and/or  other  possible  functions  required  for  the
optical properties of the normal lens.
ACKNOWLEDGMENTS
We would like to thank Dr. Robert Fariss, from the NEI Core
Imaging Facility, National Eye Institute, Bethesda, MD for
assistance with confocal microscopy imaging. Preliminary
results of this study were included in the presentation, “ERK
and JNK are required for MIP/AQUAPORIN 0 Transcription
and PKC for Translocation to the Lens Cell Membrane” at the
International Congress for Eye Research (ICER), Sydney,
Australia (2004).
REFERENCES
1. Francis  P,  Berry  V,  Bhattacharya  S,  Moore  A.  Congenital
progressive polymorphic cataract caused by a mutation in the
major  intrinsic  protein  of  the  lens,  MIP  (AQP0).  Br  J
Ophthalmol 2000; 84:1376-9. [PMID: 11090476]
2. Francis P, Chung JJ, Yasui M, Berry V, Moore A, Wyatt MK,
Wistow G, Bhattacharya SS, Agre P. Functional impairment
of lens aquaporin in two families with dominantly inherited
cataracts.  Hum  Mol  Genet  2000;  9:2329-34.  [PMID:
11001937]
3. Geyer DD, Spence MA, Johannes M, Flodman P, Clancy KP,
Berry R, Sparkes RS, Jonsen MD, Isenberg SJ, Bateman JB.
Novel  single-base  deletional  mutation  in  major  intrinsic
protein  (MIP)  in  autosomal  dominant  cataract.  Am  J
Ophthalmol 2006; 141:761-3. [PMID: 16564824]
4. Lin H, Hejtmancik JF, Qi Y. A substitution of arginine to lysine
at the COOH-terminus of MIP caused a different binocular
phenotype in a congenital cataract family. Mol Vis 2007;
13:1822-7. [PMID: 17960133]
5. Okamura T, Miyoshi I, Takahashi K, Mototani Y, Ishigaki S,
Kon Y, Kasai N. Bilateral congenital cataracts result from a
gain-of-function mutation in the gene for aquaporin-0 in mice.
Genomics 2003; 81:361-8. [PMID: 12676560]
6. Shiels A, Bassnett S. Mutations in the founder of the MIP gene
family underlie cataract development in the mouse. Nat Genet
1996; 12:212-5. [PMID: 8563764]
7. Shiels A, Bassnett S, Varadaraj K, Mathias R, Al-Ghoul K,
Kuszak J, Donoviel D, Lilleberg S, Friedrich G, Zambrowicz
B. Optical dysfunction of the crystalline lens in aquaporin-0-
deficient mice. Physiol Genomics 2001; 7:179-86. [PMID:
11773604]
8. Shiels  A,  Mackay  D,  Bassnett  S,  Al-Ghoul  K,  Kuszak  J.
Disruption of lens fiber cell architecture in mice expressing a
chimeric AQP0-LTR protein. FASEB J 2000; 14:2207-12.
[PMID: 11053241]
9. Sidjanin DJ, Parker-Wilson DM, Neuhauser-Klaus A, Pretsch
W, Favor J, Deen PM. Ohtaka-MaruyamaC, Lu Y, Bragin A,
Skach WR, Chepelinsky AB, Grimes PA, Stambolian DE. A
76-bp deletion in the Mip gene causes autosomal dominant
cataract  in  Hfi  mice.  Genomics  2001;  74:313-9.  [PMID:
11414759]
10. Gu F, Zhai H, Li D, Zhao L, Li C, Huang S, Ma X. A novel
mutation in major intrinsic protein of the lens gene (MIP)
underlies autosomal dominant cataract in a Chinese family.
Mol Vis 2007; 13:1651-6. [PMID: 17893667]
11. Berry  V,  Francis  P,  Kaushal  S,  Moore  A,  Bhattacharya  S.
Missense  mutations  in  MIP  underlie  autosomal  dominant
'polymorphic' and lamellar cataracts linked to 12q. Nat Genet
2000; 25:15-7. [PMID: 10802646]
Molecular Vision 2008; 14:1006-1014 <http://www.molvis.org/molvis/v14/a120> © 2008 Molecular Vision
101212. Yu  XS,  Jiang  JX.  Interaction  of  major  intrinsic  protein
(aquaporin-0) with fiber connexins in lens development. J
Cell Sci 2004; 117:871-80. [PMID: 14762116]
13. Yu XS, Yin X, Lafer EM, Jiang JX. Developmental regulation
of the direct interaction between the intracellular loop of
connexin 45.6 and the C-terminus of major intrinsic protein
(aquaporin-0). J Biol Chem 2005; 280:22081-90. [PMID:
15802270]
14. Gruijters WT. A non-connexon protein (MIP) is involved in eye
lens  gap-junction  formation.  J  Cell  Sci  1989;  93:509-13.
[PMID: 2691517]
15. Ball LE, Little M, Nowak MW, Garland DL, Crouch RK, Schey
KL. Water permeability of C-terminally truncated aquaporin
0 (AQP0 1–243) observed in the aging human lens. Invest
Ophthalmol Vis Sci 2003; 44:4820-8. [PMID: 14578404]
16. Chandy G, Zampighi GA, Kreman M, Hall JE. Comparison of
the water transporting properties of MIP and AQP1. J Membr
Biol 1997; 159:29-39. [PMID: 9309208]
17. Kalman K, Nemeth-Cahalan KL, Froger A, Hall JE. AQP0-
LTR  of  the  Cat  Fr  mouse  alters  water  permeability  and
calcium regulation of wild type AQP0. Biochim Biophys Acta
2006; 1758:1094-9. [PMID: 16515771]
18. Nemeth-Cahalan KL, Hall JE. pH and calcium regulate the
water  permeability  of  aquaporin  0.  J  Biol  Chem  2000;
275:6777-82. [PMID: 10702234]
19. Nemeth-Cahalan  KL,  Kalman  K,  Froger  A,  Hall  JE.  Zinc
modulation of water permeability reveals that aquaporin 0
functions  as  a  cooperative  tetramer.  J  Gen  Physiol  2007;
130:457-64. [PMID: 17938229]
20. Nemeth-Cahalan KL, Kalman K, Hall JE. Molecular basis of
pH and Ca2+ regulation of aquaporin water permeability. J
Gen Physiol 2004; 123:573-80. [PMID: 15078916]
21. Varadaraj K, Kumari S, Shiels A, Mathias RT. Regulation of
aquaporin water permeability in the lens. Invest Ophthalmol
Vis Sci 2005; 46:1393-402. [PMID: 15790907]
22. Varadaraj K, Kumari SS, Mathias RT. Functional expression of
aquaporins in embryonic, postnatal, and adult mouse lenses.
Dev Dyn 2007; 236:1319-28. [PMID: 17377981]
23. Varadaraj K, Kushmerick C, Baldo GJ, Bassnett S, Shiels A,
Mathias RT. The role of MIP in lens fiber cell membrane
transport.  J  Membr  Biol  1999;  170:191-203.  [PMID:
10441663]
24. Michea  LF,  Andrinolo  D,  Ceppi  H,  Lagos  N.  Biochemical
evidence  for  adhesion-promoting  role  of  major  intrinsic
protein isolated from both normal and cataractous human
lenses. Exp Eye Res 1995; 61:293-301. [PMID: 7556493]
25. Michea LF, de la Fuente M, Lagos N. Lens major intrinsic
protein  (MIP)  promotes  adhesion  when  reconstituted  into
large unilamellar liposomes. Biochemistry 1994; 33:7663-9.
[PMID: 8011633]
26. Gonen T, Cheng Y, Kistler J, Walz T. Aquaporin-0 membrane
junctions form upon proteolytic cleavage. J Mol Biol 2004;
342:1337-45. [PMID: 15351655]
27. Gonen T, Cheng Y, Sliz P, Hiroaki Y, Fujiyoshi Y, Harrison
SC, Walz T. Lipid-protein interactions in double-layered two-
dimensional AQP0 crystals. Nature 2005; 438:633-8. [PMID:
16319884]
28. Gonen T, Sliz P, Kistler J, Cheng Y, Walz T. Aquaporin-0
membrane junctions reveal the structure of a closed water
pore. Nature 2004; 429:193-7. [PMID: 15141214]
29. Engel A, Fujiyoshi Y, Gonen T, Walz T. Junction-forming
aquaporins. Curr Opin Struct Biol 2008; 18:229-35. [PMID:
18194855]
30. Al-Ghoul  KJ,  Kirk  T,  Kuszak  AJ,  Zoltoski  RK,  Shiels  A,
Kuszak JR. Lens structure in MIP-deficient mice. Anat Rec
A Discov Mol Cell Evol Biol 2003; 273:714-30. [PMID:
12845708]
31. Al-Ghoul KJ, Kuszak JR, Lu JY, Owens MJ. Morphology and
organization of posterior fiber ends during migration. Mol Vis
2003; 9:119-28. [PMID: 12707642]
32. Kuszak JR, Zoltoski RK, Sivertson C. Fibre cell organization
in crystalline lenses. Exp Eye Res 2004; 78:673-87. [PMID:
15106947]
33. Kuszak JR, Zoltoski RK, Tiedemann CE. Development of lens
sutures. Int J Dev Biol 2004; 48:889-902. [PMID: 15558480]
34. Fan  J,  Donovan  AK,  Ledee  DR,  Zelenka  PS,  Fariss  RN,
Chepelinsky  AB.  gammaE-crystallin  recruitment  to  the
plasma membrane by specific interaction between lens MIP/
aquaporin-0 and gammaE-crystallin. Invest Ophthalmol Vis
Sci 2004; 45:863-71. [PMID: 14985303]
35. Fan  J,  Fariss  RN,  Purkiss  AG,  Slingsby  C,  Sandilands  A,
Quinlan R, Wistow G, Chepelinsky AB. Specific interaction
between  lens  MIP/Aquaporin-0  and  two  members  of  the
gamma-crystallin family. Mol Vis 2005; 11:76-87. [PMID:
15692460]
36. Lindsey Rose KM, Gourdie RG, Prescott AR, Quinlan RA,
Crouch RK, Schey KL. The C-terminus of lens aquaporin 0
interacts with the cytoskeletal proteins filensin and CP49.
Invest  Ophthalmol  Vis  Sci  2006;  47:1562-70.  [PMID:
16565393]
37. Ball LE, Garland DL, Crouch RK, Schey KL. Post-translational
modifications of aquaporin 0 (AQP0) in the normal human
lens: spatial and temporal occurrence. Biochemistry 2004;
43:9856-65. [PMID: 15274640]
38. Schey KL, Fowler JG, Shearer TR, David L. Modifications to
rat lens major intrinsic protein in selenite-induced cataract.
Invest  Ophthalmol  Vis  Sci  1999;  40:657-67.  [PMID:
10067969]
39. Schey  KL,  Fowler  JG,  Schwartz  JC,  Busman  M,  Dillon  J,
Crouch  RK.  Complete  map  and  identification  of  the
phosphorylation site of bovine lens major intrinsic protein.
Invest  Ophthalmol  Vis  Sci  1997;  38:2508-15.  [PMID:
9375569]
40. Ehring GR, Lagos N, Zampighi GA, Hall JE. Phosphorylation
modulates the voltage dependence of channels reconstituted
from the major intrinsic protein of lens fiber membranes. J
Membr Biol 1992; 126:75-88. [PMID: 1375651]
41. Schey KL, Little M, Fowler JG, Crouch RK. Characterization
of  human  lens  major  intrinsic  protein  structure.  Invest
Ophthalmol Vis Sci 2000; 41:175-82. [PMID: 10634618]
42. Golestaneh  N,  Fan  J,  Fariss  RN,  Lo  WK,  Zelenka  PS,
Chepelinsky  AB.  Lens  major  intrinsic  protein  (MIP)/
aquaporin 0 expression in rat lens epithelia explants requires
fibroblast growth factor-induced ERK and JNK signaling. J
Biol Chem 2004; 279:31813-22. [PMID: 15145928]
43. Chamberlain  CG,  McAvoy  JW.  Induction  of  lens  fibre
differentiation by acidic and basic fibroblast growth factor
(FGF). Growth Factors 1989; 1:125-34. [PMID: 2624777]
44. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM,
Kochs  G,  Hug  H,  Marme  D,  Schachtele  C.  Selective
Molecular Vision 2008; 14:1006-1014 <http://www.molvis.org/molvis/v14/a120> © 2008 Molecular Vision
1013inhibition  of  protein  kinase  C  isozymes  by  the
indolocarbazole Go 6976. J Biol Chem 1993; 268:9194-7.
[PMID: 8486620]
45. Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller
HJ, Johannes FJ. Inhibition of protein kinase C mu by various
inhibitors. Differentiation from protein kinase c isoenzymes.
FEBS Lett 1996; 392:77-80. [PMID: 8772178]
46. Lampe  PD,  Johnson  RG.  Phosphorylation  of  MP26,  a  lens
junction protein, is enhanced by activators of protein kinase
C. J Membr Biol 1989; 107:145-55. [PMID: 2541249]
47. Obenauer JC, Cantley LC, Yaffe MB. Scansite 2.0: Proteome-
wide  prediction  of  cell  signaling  interactions  using  short
sequence  motifs.  Nucleic  Acids  Res  2003;  31:3635-41.
[PMID: 12824383]
48. Ghosh RN, Mallet WG, Soe TT, McGraw TE, Maxfield FR. An
endocytosed TGN38 chimeric protein is delivered to the TGN
after trafficking through the endocytic recycling compartment
in CHO cells. J Cell Biol 1998; 142:923-36. [PMID: 9722606]
49. Rohn WM, Rouille Y, Waguri S, Hoflack B. Bi-directional
trafficking  between  the  trans-Golgi  network  and  the
endosomal/lysosomal  system.  J  Cell  Sci  2000;
113:2093-101. [PMID: 10825282]
50. Sabatini DD, Adesnik M, Ivanov IE, Simon JP. Mechanism of
formation of post Golgi vesicles from TGN membranes: Arf-
dependent coat assembly and PKC-regulated vesicle scission.
Biocell 1996; 20:287-300. [PMID: 9031596]
51. Bao J, Alroy I, Waterman H, Schejter ED, Brodie C, Gruenberg
J, Yarden Y. Threonine phosphorylation diverts internalized
epidermal  growth  factor  receptors  from  a  degradative
pathway  to  the  recycling  endosome.  J  Biol  Chem  2000;
275:26178-86. [PMID: 10816576]
52. Molloy SS, Anderson ED, Jean F, Thomas G. Bi-cycling the
furin pathway: from TGN localization to pathogen activation
and embryogenesis. Trends Cell Biol 1999; 9:28-35. [PMID:
10087614]
53. Zehavi-Feferman R, Burgess JW, Stanley KK. Control of p62
binding to TGN38/41 by phosphorylation. FEBS Lett 1995;
368:122-4. [PMID: 7615064]
54. Wagner  LM,  Takemoto  DJ.  PKCalpha  and  PKCgamma
overexpression causes lentoid body formation in the N/N
1003A  rabbit  lens  epithelial  cell  line.  Mol  Vis  2001;
7:138-44. [PMID: 11436000]
55. Berthoud VM, Westphale EM, Grigoryeva A, Beyer EC. PKC
isoenzymes in the chicken lens and TPA-induced effects on
intercellular  communication.  Invest  Ophthalmol  Vis  Sci
2000; 41:850-8. [PMID: 10711703]
56. Saleh  SM,  Takemoto  LJ,  Zoukhri  D,  Takemoto  DJ.  PKC-
gamma phosphorylation of connexin 46 in the lens cortex.
Mol Vis 2001; 7:240-6. [PMID: 11702063]
57. Lampe PD, TenBroek EM, Burt JM, Kurata WE, Johnson RG,
Lau  AF.  Phosphorylation  of  connexin43  on  serine368  by
protein kinase C regulates gap junctional communication. J
Cell Biol 2000; 149:1503-12. [PMID: 10871288]
58. Lin  D,  Boyle  DL,  Takemoto  DJ.  IGF-I-induced
phosphorylation of connexin 43 by PKCgamma: regulation
of  gap  junctions  in  rabbit  lens  epithelial  cells.  Invest
Ophthalmol Vis Sci 2003; 44:1160-8. [PMID: 12601045]
59. Lin  D,  Lobell  S,  Jewell  A,  Takemoto  DJ.  Differential
phosphorylation of connexin46 and connexin50 by H2O2
activation  of  protein  kinase  Cgamma.  Mol  Vis  2004;
10:688-95. [PMID: 15467523]
60. Lin D, Shanks D, Prakash O, Takemoto DJ. Protein kinase C
gamma mutations in the C1B domain cause caspase-3-linked
apoptosis in lens epithelial cells through gap junctions. Exp
Eye Res 2007; 85:113-22. [PMID: 17493614]
61. Lin  D,  Zhou  J,  Zelenka  PS,  Takemoto  DJ.  Protein  kinase
Cgamma  regulation  of  gap  junction  activity  through
caveolin-1-containing lipid rafts. Invest Ophthalmol Vis Sci
2003; 44:5259-68. [PMID: 14638725]
62. Lurtz MM, Louis CF. Calmodulin and protein kinase C regulate
gap junctional coupling in lens epithelial cells. Am J Physiol
Cell Physiol 2003; 285:C1475-82. [PMID: 12917107]
63. Zampighi GA, Planells AM, Lin D, Takemoto D. Regulation of
lens cell-to-cell communication by activation of PKCgamma
and disassembly of Cx50 channels. Invest Ophthalmol Vis
Sci 2005; 46:3247-55. [PMID: 16123426]
64. Wagner LM, Fowler VM, Takemoto DJ. The interaction and
phosphorylation of tropomodulin by protein kinase Calpha in
N/N 1003A lens epithelial cells. Mol Vis 2002; 8:394-406.
[PMID: 12419997]
65. Scott DB, Blanpied TA, Ehlers MD. Coordinated PKA and PKC
phosphorylation suppresses RXR-mediated ER retention and
regulates  the  surface  delivery  of  NMDA  receptors.
Neuropharmacology 2003; 45:755-67. [PMID: 14529714]
66. Scott DB, Blanpied TA, Swanson GT, Zhang C, Ehlers MD. An
NMDA  receptor  ER  retention  signal  regulated  by
phosphorylation and alternative splicing. J Neurosci 2001;
21:3063-72. [PMID: 11312291]
67. van Tiel CM, Westerman J, Paasman MA, Hoebens MM, Wirtz
KW,  Snoek  GT.  The  Golgi  localization  of
phosphatidylinositol transfer protein beta requires the protein
kinase  C-dependent  phosphorylation  of  serine  262  and  is
essential for maintaining plasma membrane sphingomyelin
levels. J Biol Chem 2002; 277:22447-52. [PMID: 11953429]
68. Lan JY, Skeberdis VA, Jover T, Grooms SY, Lin Y, Araneda
RC,  Zheng  X,  Bennett  MV,  Zukin  RS.  Protein  kinase  C
modulates  NMDA  receptor  trafficking  and  gating.  Nat
Neurosci 2001; 4:382-90. [PMID: 11276228]
69. Hausser A, Storz P, Martens S, Link G, Toker A, Pfizenmaier
K.  Protein  kinase  D  regulates  vesicular  transport  by
phosphorylating and activating phosphatidylinositol-4 kinase
IIIbeta at the Golgi complex. Nat Cell Biol 2005; 7:880-6.
[PMID: 16100512]
70. Yeaman C, Ayala MI, Wright JR, Bard F, Bossard C, Ang A,
Maeda Y, Seufferlein T, Mellman I, Nelson WJ, Malhotra V.
Protein kinase D regulates basolateral membrane protein exit
from  trans-Golgi  network.  Nat  Cell  Biol  2004;  6:106-12.
[PMID: 14743217]
71. Rose KM, Wang Z, Magrath GN, Hazard ES, Hildebrandt JD,
Schey KL. Aquaporin 0-calmodulin interaction and the effect
of  aquaporin  0  phosphorylation.  Biochemistry  2008;
47:339-47. [PMID: 18081321]
Molecular Vision 2008; 14:1006-1014 <http://www.molvis.org/molvis/v14/a120> © 2008 Molecular Vision
The print version of this article was created on 29 May 2008. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
1014